DAPACOSE 10 10'S

About

Dapacose 10 (Dapagliflozin) 10 mg is a selective sodium-glucose co-transporter 2 (SGLT2) inhibitor indicated for improving glycemic control in adults with type 2 diabetes. Its primary mechanism involves blocking the SGLT2 protein in the renal tubules, which prevents the reabsorption of glucose and promotes its excretion in the urine, leading to a reduction in blood glucose levels. Beyond its antidiabetic effects, dapagliflozin has demonstrated remarkable benefits in cardiovascular and renal health. It is specifically indicated for reducing the risk of cardiovascular death and hospitalization for heart failure in adults with heart failure, and for reducing the risk of sustained eGFR decline, end-stage kidney disease, cardiovascular death, and hospitalization for heart failure in adults with chronic kidney disease, making it a multifaceted therapeutic agent.

Uses

• Management of type 2 diabetes mellitus.
• To reduce the risk of cardiovascular death and hospitalization for heart failure in adults with heart failure.
• To reduce the risk of sustained eGFR decline, end-stage kidney disease, cardiovascular death, and hospitalization for heart failure in adults with chronic kidney disease.
• As an adjunct to diet and exercise.

Directions For Use

Take orally once daily in the morning, with or without food, as directed by your doctor.

Benefits

• Effective blood sugar reduction.
• Lowered HbA1c levels.
• Promotes modest weight loss.
• Reduces risk of cardiovascular events.
• Slows progression of kidney disease.
• Low risk of hypoglycemia as monotherapy.

Side Effects

• Urinary tract infections
• Genital yeast infections
• Increased urination
• Thirst
• Back pain
• Nausea
• Dizziness
• Hypotension (especially at initiation)
• Ketoacidosis (rare)
• Flu-like symptoms
• Dyslipidemia
• Increased hematocrit

Safety Measures

• Alcohol - Moderate alcohol consumption is generally acceptable, but excessive intake may increase the risk of dehydration or ketoacidosis.
• Pregnancy - Not recommended during pregnancy, especially in the second and third trimesters. Consult your doctor.
• Breastfeeding - Not recommended during breastfeeding as it may pass into breast milk. Consult your doctor.
• Liver - Generally safe, but use with caution in severe hepatic impairment as data are limited.
• Kidney - Contraindicated in severe renal impairment or end-stage renal disease. Dose adjustment may be needed based on eGFR.
• Lung - Generally safe, no specific contraindications related to lung conditions.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.